BRPI1015108A2 - pró-fármacos de aminoácidos e peptídios ligados a ácido dicarboxílico de opiáceos e seus usos - Google Patents
pró-fármacos de aminoácidos e peptídios ligados a ácido dicarboxílico de opiáceos e seus usosInfo
- Publication number
- BRPI1015108A2 BRPI1015108A2 BRPI1015108A BRPI1015108A BRPI1015108A2 BR PI1015108 A2 BRPI1015108 A2 BR PI1015108A2 BR PI1015108 A BRPI1015108 A BR PI1015108A BR PI1015108 A BRPI1015108 A BR PI1015108A BR PI1015108 A2 BRPI1015108 A2 BR PI1015108A2
- Authority
- BR
- Brazil
- Prior art keywords
- opioid
- amino acid
- linked amino
- dicarboxylic acid
- peptide prodrugs
- Prior art date
Links
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21183109P | 2009-04-02 | 2009-04-02 | |
| US22771609P | 2009-07-22 | 2009-07-22 | |
| PCT/GB2010/050584 WO2010112942A1 (en) | 2009-04-02 | 2010-04-01 | Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1015108A2 true BRPI1015108A2 (pt) | 2016-04-26 |
Family
ID=42238240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1015108A BRPI1015108A2 (pt) | 2009-04-02 | 2010-04-01 | pró-fármacos de aminoácidos e peptídios ligados a ácido dicarboxílico de opiáceos e seus usos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100286186A1 (pt) |
| EP (1) | EP2413937A1 (pt) |
| JP (1) | JP2013523599A (pt) |
| KR (1) | KR20110134510A (pt) |
| CN (1) | CN102573845A (pt) |
| AU (1) | AU2010231126A1 (pt) |
| BR (1) | BRPI1015108A2 (pt) |
| CA (1) | CA2756397A1 (pt) |
| IL (1) | IL215348A0 (pt) |
| MX (1) | MX2011010448A (pt) |
| WO (1) | WO2010112942A1 (pt) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090192095A1 (en) * | 2008-01-18 | 2009-07-30 | Shire Llc | Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| WO2010045599A1 (en) | 2008-10-17 | 2010-04-22 | Pharmacofore, Inc. | Pharmaceutical compositions with attenuated release of phenolic opioids |
| CN102695545B (zh) | 2009-09-08 | 2016-08-17 | 特色疗法股份有限公司 | 包括酶可剪切的酮改性的阿片样物质药物前体以及其可任选的抑制剂的组合物 |
| WO2011133178A1 (en) | 2010-04-21 | 2011-10-27 | Pharmacofore, Inc | Compositions comprising enzyme-cleavable phenol-modified tapentadol prodrug |
| US20110262355A1 (en) | 2010-04-21 | 2011-10-27 | Jenkins Thomas E | Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof |
| US20130059914A1 (en) | 2010-04-21 | 2013-03-07 | Signature Therapeutics, Inc. | Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof |
| PH12012502083A1 (en) | 2010-05-10 | 2017-07-26 | Euro Celtique Sa | Manufacturing of active-free granules and tablets comprising the same |
| US9700508B2 (en) | 2010-05-10 | 2017-07-11 | Euro-Celtique S.A. | Pharmaceutical compositions comprising hydromorphone and naloxone |
| EP2568965A1 (en) | 2010-05-10 | 2013-03-20 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
| AU2012205733B2 (en) * | 2011-01-11 | 2015-10-08 | Signature Therapeutics, Inc. | Compositions comprising enzyme-cleavable oxycodone prodrug |
| US8497237B2 (en) | 2011-01-11 | 2013-07-30 | Signature Therapeutics, Inc. | Compositions comprising enzyme-cleavable oxycodone prodrug |
| JP2014503592A (ja) | 2011-01-26 | 2014-02-13 | ニコ ワールドワイド，インコーポレイテッド | 片頭痛の療法 |
| WO2012122420A2 (en) | 2011-03-09 | 2012-09-13 | Pharmacofore, Inc. | Opioid prodrugs with heterocyclic linkers |
| JP6148182B2 (ja) | 2011-03-09 | 2017-06-14 | シグネーチャー セラピューティクス, インク.Signature Therapeutics, Inc. | 複素環式リンカーを有する活性薬剤プロドラッグ |
| US9918980B2 (en) | 2011-04-29 | 2018-03-20 | Rutgers, The State University Of New Jersey | Method of treating dyskinesia |
| US10736889B2 (en) | 2011-04-29 | 2020-08-11 | Rutgers, The State University Of New Jersey | Method of treating dyskinesia |
| DK2701707T3 (da) | 2011-04-29 | 2020-11-02 | Univ Rutgers | Fremgangsmåde til behandling af dyskinesi |
| WO2013093931A2 (en) | 2011-09-19 | 2013-06-27 | Sun Pharma Advanced Research Company Ltd. | Novel prodrugs of phenolic drugs |
| SG11201401856VA (en) | 2011-10-26 | 2014-05-29 | Kempharm Inc | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof |
| WO2014031403A1 (en) * | 2012-08-22 | 2014-02-27 | Phoenix Pharmalabs, Inc. | Use of morphine analogs for animal health |
| GB201315335D0 (en) | 2013-08-29 | 2013-10-09 | Of Singapore | Amino diacids containing peptide modifiers |
| WO2015071380A1 (en) | 2013-11-13 | 2015-05-21 | Euro-Celtique S.A. | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
| ES2784690T3 (es) | 2013-12-05 | 2020-09-29 | Univ Bath | Nuevos compuestos opioides y sus usos |
| CA2875384A1 (en) | 2013-12-20 | 2015-06-20 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
| RU2683274C2 (ru) | 2014-12-02 | 2019-03-27 | Кемфарм, Инк. | Бензойная кислота, производные бензойной кислоты и конъюгаты гетероарилкарбоновой кислоты и оксиморфона, их пролекарства, способы получения и применение |
| US10017519B2 (en) * | 2015-04-27 | 2018-07-10 | 3St Research Llc | Alpha-hydroxy carboxylic acid and derivatives and other GRAS based prodrugs of oxycodone and uses thereof |
| US9987269B2 (en) * | 2015-04-27 | 2018-06-05 | 3St Research Llc | Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of oxymorphone and uses thereof |
| US10449190B2 (en) | 2015-04-27 | 2019-10-22 | John K. Thottathil | Alpha-hydroxy carboxylic acid and derivatives and other GRAS-based prodrugs of opioids and uses thereof |
| US10226456B2 (en) * | 2015-04-27 | 2019-03-12 | 3St Research Llc | Methods and compositions for preventing opioid abuse |
| US10286079B2 (en) | 2015-09-22 | 2019-05-14 | The Regents Of The University Of California | Modified cytotoxins and their therapeutic use |
| CA2998528A1 (en) | 2015-09-22 | 2017-03-30 | The Regents Of The University Of California | Modified cytotoxins and their therapeutic use |
| CN106866733B (zh) * | 2015-12-11 | 2020-11-20 | 凯瑞康宁生物工程（武汉）有限公司 | 左旋美普他酚前药及其制备方法和用途 |
| CN110054568B (zh) * | 2016-01-04 | 2020-01-14 | 山东丹红制药有限公司 | 地佐辛类似物 |
| CN113429306A (zh) * | 2016-08-26 | 2021-09-24 | 江苏恩华药业股份有限公司 | 一种地佐辛晶型a及其制备方法 |
| WO2018183264A1 (en) * | 2017-03-29 | 2018-10-04 | Thottathil John K | Novel alpha-hydroxy carboxylic acid and derivatives and other gras- based prodrugs of opioids and uses thereof |
| US11234975B2 (en) | 2017-04-14 | 2022-02-01 | Kempharm, Inc. | Levorphanol prodrugs and processes for making and using them |
| WO2018191477A1 (en) * | 2017-04-14 | 2018-10-18 | Kempharm, Inc. | Dextrorphan prodrugs and processes for making and using them |
| WO2018191474A1 (en) * | 2017-04-14 | 2018-10-18 | Kempharm, Inc. | Levorphanol prodrugs and processes for making and using them |
| WO2019007285A1 (zh) * | 2017-07-03 | 2019-01-10 | 山东丹红制药有限公司 | 地佐辛类似物盐酸盐的晶型及无定型 |
| AU2019224127B2 (en) * | 2018-02-23 | 2021-12-09 | Rhodes Technologies | Novel opioid compounds and uses thereof |
| WO2020012245A1 (en) | 2018-07-13 | 2020-01-16 | Alkermes Pharma Ireland Limited | Thienothiophene-naltrexone prodrugs for long-acting injectable compositions |
| US10799496B2 (en) | 2018-07-13 | 2020-10-13 | Alkermes Pharma Ireland Limited | Naphthylenyl compounds for long-acting injectable compositions and related methods |
| US11186585B2 (en) | 2018-08-17 | 2021-11-30 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
| CN109096191B (zh) * | 2018-10-25 | 2022-03-08 | 西北工业大学 | 氟比洛芬美普他酚酯药用化合物及其制备方法 |
| US10975099B2 (en) | 2018-11-05 | 2021-04-13 | Alkermes Pharma Ireland Limited | Thiophene compounds for long-acting injectable compositions and related methods |
| CA3149152A1 (en) | 2019-08-11 | 2021-02-18 | Kappa-Pharma LLC | Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates |
| PE20230405A1 (es) * | 2019-10-29 | 2023-03-07 | Univ Johns Hopkins | Profarmacos de itaconato e itaconato de metilo desarrollo o investigacion patrocinados por el gobierno |
| IL294601A (en) | 2020-01-10 | 2022-09-01 | Trevi Therapeutics Inc | Methods of administration of nalbuphine |
| IL305493A (en) | 2021-03-09 | 2023-10-01 | Ensysce Biosciences Inc | Compositions comprising enzyme-cleavable prodrugs and controlled release nafamostat and methods of use thereof |
| CA3230025A1 (en) | 2021-09-29 | 2023-04-06 | Lynn Kirkpatrick | Enzyme-cleavable methadone prodrugs and methods of use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256669A (en) * | 1992-08-07 | 1993-10-26 | Aminotek Sciences, Inc. | Methods and compositions for treating acute or chronic pain and drug addiction |
| US7060708B2 (en) * | 1999-03-10 | 2006-06-13 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| KR100786927B1 (ko) | 2000-06-28 | 2007-12-17 | 스미스클라인비이참피이엘시이 | 습식 분쇄방법 |
| ZA200504940B (en) * | 2003-01-28 | 2006-09-27 | Xenoport Inc | Amino acid derived prodrugs of propofol, compositions and uses thereof |
| JP2006520392A (ja) * | 2003-03-13 | 2006-09-07 | コントロールド・ケミカルズ・インコーポレーテッド | 薬物の乱用可能性を低下させ且つ作用持続時間を延長する化合物および方法 |
| JP2007517877A (ja) * | 2004-01-15 | 2007-07-05 | ワーナー・チルコット・カンパニー・インコーポレーテッド | エストラジオールのジ−ステロイド型プロドラッグ |
| EP1804838A2 (en) * | 2004-09-15 | 2007-07-11 | Drug Discovery Laboratory AS | Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| MX2008014794A (es) * | 2006-05-26 | 2009-04-08 | Pharmacofore Inc | Liberacion controlada de opioides fenolicos. |
| US20090192095A1 (en) * | 2008-01-18 | 2009-07-30 | Shire Llc | Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
-
2010
- 2010-04-01 BR BRPI1015108A patent/BRPI1015108A2/pt not_active Application Discontinuation
- 2010-04-01 EP EP10712960A patent/EP2413937A1/en not_active Withdrawn
- 2010-04-01 MX MX2011010448A patent/MX2011010448A/es not_active Application Discontinuation
- 2010-04-01 CN CN2010800236508A patent/CN102573845A/zh active Pending
- 2010-04-01 WO PCT/GB2010/050584 patent/WO2010112942A1/en not_active Ceased
- 2010-04-01 CA CA2756397A patent/CA2756397A1/en not_active Abandoned
- 2010-04-01 KR KR1020117026004A patent/KR20110134510A/ko not_active Withdrawn
- 2010-04-01 AU AU2010231126A patent/AU2010231126A1/en not_active Abandoned
- 2010-04-01 JP JP2012502812A patent/JP2013523599A/ja not_active Withdrawn
- 2010-04-01 US US12/753,042 patent/US20100286186A1/en not_active Abandoned
-
2011
- 2011-09-25 IL IL215348A patent/IL215348A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013523599A (ja) | 2013-06-17 |
| MX2011010448A (es) | 2011-10-28 |
| CA2756397A1 (en) | 2010-10-07 |
| US20100286186A1 (en) | 2010-11-11 |
| CN102573845A (zh) | 2012-07-11 |
| AU2010231126A1 (en) | 2011-10-13 |
| WO2010112942A1 (en) | 2010-10-07 |
| KR20110134510A (ko) | 2011-12-14 |
| IL215348A0 (en) | 2011-12-29 |
| EP2413937A1 (en) | 2012-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1015108A2 (pt) | pró-fármacos de aminoácidos e peptídios ligados a ácido dicarboxílico de opiáceos e seus usos | |
| BR112012001164A2 (pt) | aminoácido de carbamato e pró-fármacos de peptídeo de opioides e usos dos mesmos | |
| PL2391620T3 (pl) | Alkiloamino-podstawione dicyjanopirydyny i ich estrowe proleki aminokwasów | |
| EP2432489A4 (en) | VARIANTS OF THE NATRIURETIC PEPTIDE TYPE C | |
| DK2408758T3 (da) | Krystallin tripeptid-epoxy-keton-protease-inhibitorer | |
| DK2349217T3 (da) | Gamma-hydroxysmørsyre-granulat | |
| BRPI1009192A2 (pt) | preparação de ácido adípico | |
| IT1399032B1 (it) | Poliestere biodegradabile alifatico-aromatico | |
| DK2515928T3 (da) | Oxyntomodulin peptidanalog | |
| IL248880A0 (en) | Preparations containing r-g-cysteic acid peptides and their uses | |
| PT2464370T (pt) | Péptidos vasoativos intestinais modificados | |
| IL188681A0 (en) | Pharmaceutical compositions and methods utilizing a d-amino acid | |
| BR112012001551A2 (pt) | profármacos de aminoácido galantamina e peptídeo e usos dos mesmos | |
| BRPI1010661A2 (pt) | peptídeo | |
| PT2427417E (pt) | Sais de ácido 3-pentilfenilacético e usos farmacêuticos dos mesmos | |
| EP2447264A4 (en) | N-SUBSTITUTED CYCLIC AMINO DERIVATIVE | |
| ZA201102450B (en) | Amino acid derivative | |
| GB0901750D0 (en) | Fencing signage | |
| GB0918455D0 (en) | Trading post | |
| GB0906872D0 (en) | Amino acid derivatives | |
| AU4371P (en) | DrisStrawEleven Fragaria x ananassa | |
| AU4452P (en) | DrisStrawNine Fragaria x ananassa | |
| AU4373P (en) | DrisStrawEight Fragaria x ananassa | |
| AU4372P (en) | DrisStrawThirteen Fragaria x ananassa | |
| AU4355P (en) | DrisStrawSix Fragaria x ananassa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |